Lixisenatide Subcutaneous and Polatuzumab Vedotin-piiq
Determining the interaction of Lixisenatide Subcutaneous and Polatuzumab Vedotin-piiq and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lixisenatide
Brand name: Adlyxin
Synonyms: Lixisenatide
Generic Name: polatuzumab vedotin
Brand name: Polivy
Synonyms: Polatuzumab vedotin, Polatuzumab Vedotin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lixisenatide Subcutaneous-Polio vaccine, inactivated
- Lixisenatide Subcutaneous-Poliovirus Vaccine (Inactivated)
- Lixisenatide Subcutaneous-Poliovirus vaccine, inactivated Injection
- Lixisenatide Subcutaneous-Polivy
- Lixisenatide Subcutaneous-Polmon
- Lixisenatide Subcutaneous-Polocaine
- Polatuzumab Vedotin-piiq-Lixtraxen Injection
- Polatuzumab Vedotin-piiq-LMD
- Polatuzumab Vedotin-piiq-LMD Injection
- Polatuzumab Vedotin-piiq-LMX 4 Topical application
- Polatuzumab Vedotin-piiq-LMX 5
- Polatuzumab Vedotin-piiq-LMX 5 Topical application